Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

46 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 18 fdg - - - - 1件: 145 💬
2 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
3 Acth Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 5件: 13, 66, 145, 193, 222 💬
4 Adrenocorticotropin hormone - - - - 1件: 145 💬
5 Cannabidiol Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 17件:  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
6 Cannabidiol (cbd) Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 6件:  6 , 140, 144, 145, 156, 158 💬
7 Cannabidiol oral solution Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 4件: 140, 144, 145, 193 💬
8 Cbd - - - - 11件:  2 ,  6 ,  8 , 13, 46, 140, 144, 145, 156, 158, 206 💬
9 Combination therapy with vigabatrin and prednisolone Prednisolone 9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 2件: ABAT, NR3C1 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
10 Cosyntropin Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 3件: 83, 113, 145 💬
11 Cosyntropin injectable suspension 1 mg/ml + vigabatrin Tetracosactide 2件: D00284, D00535 💬 2件: ABAT, MC2R 💬 12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 1件: 145 💬
12 Cosyntropin injectable suspension, 1 mg/ml Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 145 💬
13 Decortin h - - - - 3件: 66, 97, 145 💬
14 Fenfluramine Fenfluramine 1件: D07945 💬 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 3件: 140, 144, 145 💬
15 Ganaxolone Ganaxolone 1件: D04300 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 4件: 145, 152, 158, 206 💬
16 Gwp42003-p - - - - 5件: 140, 144, 145, 156, 158 💬
17 Intravenous methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 145 💬
18 Jbpos0101 JBPOS0101 - - - 1件: 145 💬
19 M071754 - - - - 1件: 145 💬
20 Melatonin Melatonin 1件: D08170 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 11件:  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
21 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
22 Modified atkins diet - - - - 2件: 145, 157 💬
23 Null - - - - 16件:  6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
24 Oral pednisolone - - - - 1件: 145 💬
25 Oral prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 49, 145 💬
26 Other: modified atkins diet - - - - 1件: 145 💬
27 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
28 Pyridoxine Pyridoxine 2件: D02179, D08454 💬 - - 2件: 93, 145 💬
29 Pyridoxine plus prednisolone Prednisolone 10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
30 Radiprodil Radiprodil - - - 1件: 145 💬
31 Sabril - - - - 1件: 145 💬
32 Sabril granules for oral use - - - - 1件: 145 💬
33 Sabril sachets - - - - 1件: 145 💬
34 Sabrilex - - - - 1件: 145 💬
35 Sabril® - - - - 1件: 145 💬
36 Soluble prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
37 Spt3162 - - - - 1件: 145 💬
38 Synacthen depot - - - - 3件: 83, 145, 222 💬
39 Tetracosactide Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 4件: 83, 113, 145, 222 💬
40 Tetracosactide acetate Acetate 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 2件: 83, 145 💬
41 Ucb3491 - - - - 1件: 145 💬
42 Vgb-st - - - - 1件: 145 💬
43 Vgb-st soluble tablets - - - - 1件: 145 💬
44 Vigabatrin Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 2件: 145, 158 💬
45 Vigabatrin tablets Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
46 Vigabatrin: vigabatrin new st formulation then sabril® Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬

先頭へ